Hjem › Multipelt myelom › Iowa › Cedar Rapids
Multipelt myelom kliniske forsøg i Cedar Rapids, IA
15 studier for Multipelt myelom søger deltagere på steder i og omkring Cedar Rapids (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi væk
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
RekruttererFase 1
- Research Site, Iowa City · 25 mi væk
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- University of Iowa Hospital and Clinics, Iowa City · 25 mi væk
Collection of Tissue Samples for Cancer Research
RekruttererObservationsstudie
- University of Iowa, Iowa City · 25 mi væk
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 2
- University of Iowa, Iowa City · 25 mi væk
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RekruttererFase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
RekruttererFase 1/2
- Research Site, Iowa City · 25 mi væk
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekruttererFase 3
- Research Site, Iowa City · 25 mi væk
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
RekruttererFase 2
- University of Iowa, Iowa City · 25 mi væk
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RekruttererFase 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi væk
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
RekruttererFase 2
- University of Iowa, Iowa City · 25 mi væk
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
RekruttererFase 1
- University of Iowa Health Care, Iowa City · 25 mi væk
Sleep Apnea in Patients With MGUS and MM
RekruttererObservationsstudie
- University of Iowa, Iowa City · 25 mi væk
Activity Levels in Bone Marrow Transplant Patients
RekruttererObservationsstudie
- University of Iowa, Iowa City · 25 mi væk
Limited-duration Teclistamab
RekruttererFase 2
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi væk
Multipelt myelom forsøg i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Cedar Rapids
- Ikke-småcellet lungecancer20 studier
- Brystkræft17 studier
- Akut myeloid leukæmi16 studier
- Kræft (alle typer)15 studier
- Lungecancer14 studier
- Colorektal kræft13 studier
- Prostatakræft12 studier
- Pladecellekræft i hoved og hals12 studier
- Melanom10 studier
- Slagtilfælde10 studier
- Metastatisk cancer9 studier
- Livmoderslimhindekræft9 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.